BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Prelude Therapeutics Announces Strategic Business Update

  November 4, 2025

   · 

  10 min read
• Press Releases

  Kane Biotech Presents revyve® Data at Diabetic Foot and Southern Region Burn Conferences

  November 4, 2025

   · 

  5 min read
• Press Releases

  Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

  November 4, 2025

   · 

  4 min read
• Press Releases

  RadNet Announces the Agenda for its November 11, 2025 Investor Day

  November 4, 2025

   · 

  2 min read
• Press Releases

  Celcuity To Present at Upcoming Stifel 2025 Healthcare Conference

  November 4, 2025

   · 

  2 min read
• Press Releases

  Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights

  November 4, 2025

   · 

  27 min read
• Press Releases

  AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

  November 4, 2025

   · 

  11 min read
• Press Releases

  Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer

  November 4, 2025

   · 

  6 min read
• Press Releases

  Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors

  November 4, 2025

   · 

  7 min read
• Press Releases

  Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients

  November 4, 2025

   · 

  5 min read